Corporate

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Corporate

Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development

Corporate

9 July 2019

MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)

Corporate

5 April 2019

MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management

Corporate

11 March 2019

MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation

Corporate

24 January 2019

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.